Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

BUY
$42.05 - $47.77 $196,205 - $222,894
4,666 Added 96.78%
9,487 $413,000
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $187,713 - $222,754
-4,666 Reduced 49.18%
4,821 $210,000
Q4 2021

Feb 15, 2022

BUY
$38.88 - $45.31 $368,854 - $429,855
9,487 New
9,487 $418,000
Q2 2021

Aug 18, 2021

SELL
$36.52 - $41.46 $205,132 - $232,880
-5,617 Closed
0 $0
Q1 2021

May 21, 2021

SELL
$34.27 - $40.01 $162,576 - $189,807
-4,744 Reduced 45.79%
5,617 $200,000
Q4 2020

Feb 16, 2021

BUY
$34.07 - $39.94 $166,874 - $195,626
4,898 Added 89.66%
10,361 $381,000
Q3 2020

Nov 17, 2020

SELL
$38.11 - $42.99 $17,721 - $19,990
-465 Reduced 7.84%
5,463 $206,000
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $7,649 - $8,803
-202 Reduced 3.3%
5,928 $242,000
Q1 2020

May 18, 2020

SELL
$32.47 - $48.83 $11,332 - $17,041
-349 Reduced 5.39%
6,130 $232,000
Q4 2019

Feb 18, 2020

SELL
$42.0 - $48.25 $13,944 - $16,019
-332 Reduced 4.87%
6,479 $304,000
Q3 2019

Nov 26, 2019

SELL
$40.46 - $43.52 $64,897 - $69,806
-1,604 Reduced 19.06%
6,811 $291,000
Q2 2019

Aug 19, 2019

SELL
$39.4 - $42.7 $57,366 - $62,171
-1,456 Reduced 14.75%
8,415 $337,000
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $169,206 - $187,281
4,387 Added 80.0%
9,871 $413,000
Q4 2018

Feb 15, 2019

BUY
$37.8 - $42.69 $1,134 - $1,280
30 Added 0.55%
5,484 $210,000
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $6,081 - $6,531
153 Added 2.89%
5,454 $219,000
Q2 2018

Aug 15, 2018

SELL
$39.61 - $42.76 $277 - $299
-7 Reduced 0.13%
5,301 $214,000
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $192,043 - $213,116
5,308 New
5,308 $207,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.